TabletsClinical Overview
Deflazacort Tablets (6mg) is an oral synthetic oxazoline derivative of prednisolone on the PMBI formulary. It exerts powerful anti-inflammatory and immunosuppressive actions with significantly lower bone mineral resorption, reduced osteoclastogenesis, and lower diabetogenic/weight gain liability compared to conventional prednisone or dexamethasone. Indicated for severe refractory bronchial asthma, allergic disorders, and Duchenne muscular dystrophy.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily in the morning with breakfast with a glass of water. Swallow whole. Never discontinue abruptly; taper gradually.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Increased appetite, weight gain, facial rounding (cushingoid features), insomnia, dyspepsia. Rare/Severe: Adrenal suppression, osteoporosis, cataracts, and opportunistic infections.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Do NOT stop taking abruptly (risk of acute adrenal crisis); taper dose gradually under medical supervision. Monitor blood pressure and blood glucose.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Deflazacort 30mg + Tamsulosin 0.4mg Tablets
Deflazacort (30mg) and Tamsulosin (0.4mg) Tablets is a specialized medical expulsive therapy (MET) combination. Tamsulosin blocks alpha-1D receptors located predominantly in the lower third of the ureter and ureterovesical junction (UVJ), inhibiting ureteral smooth muscle spasm and dilating the ureteral lumen. Deflazacort is an oxazoline glucocorticoid that exerts potent anti-inflammatory and anti-edematous action around the impacted stone site, reducing localized mucosal swelling and pain. Indicated for medical expulsive therapy of distal ureteral calculi (stones measuring 5 to 10 mm) to accelerate spontaneous stone passage and reduce surgical intervention.
Deflazacort oral Suspension 6mg per 5ml
Deflazacort Oral Suspension 6 mg per 5 ml is an oxazoline derivative of prednisolone with high glucocorticoid and minimal mineralocorticoid activity. In comparative clinical trials, it exhibits a more favorable metabolic and bone safety profile, causing significantly less calcium loss, bone demineralization, growth retardation, and carbohydrate intolerance than conventional prednisone or prednisolone. Indicated for Duchenne muscular dystrophy (DMD) in pediatric patients (age >=2 years), juvenile idiopathic arthritis, severe pediatric asthma, nephrotic syndrome, and chronic autoimmune disorders.